JP2022534796A5 - - Google Patents
Info
- Publication number
- JP2022534796A5 JP2022534796A5 JP2021572295A JP2021572295A JP2022534796A5 JP 2022534796 A5 JP2022534796 A5 JP 2022534796A5 JP 2021572295 A JP2021572295 A JP 2021572295A JP 2021572295 A JP2021572295 A JP 2021572295A JP 2022534796 A5 JP2022534796 A5 JP 2022534796A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- therapeutic agent
- ratio
- plga
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962858478P | 2019-06-07 | 2019-06-07 | |
| US62/858,478 | 2019-06-07 | ||
| PCT/US2020/036040 WO2020247576A1 (en) | 2019-06-07 | 2020-06-04 | Compositions and methods relating to erythrocytes with adhered particles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022534796A JP2022534796A (ja) | 2022-08-03 |
| JP2022534796A5 true JP2022534796A5 (https=) | 2023-05-09 |
| JP7561146B2 JP7561146B2 (ja) | 2024-10-03 |
Family
ID=73652929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021572295A Active JP7561146B2 (ja) | 2019-06-07 | 2020-06-04 | 接着している粒子を有する赤血球に関連する組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220323603A1 (https=) |
| EP (1) | EP3979994A4 (https=) |
| JP (1) | JP7561146B2 (https=) |
| CN (1) | CN114222564A (https=) |
| AU (1) | AU2020287620B2 (https=) |
| CA (1) | CA3140681A1 (https=) |
| IL (1) | IL288743B2 (https=) |
| WO (1) | WO2020247576A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3180060A1 (en) * | 2020-05-29 | 2021-12-02 | Zongmin ZHAO | Living cells engineered with polyphenol-functionalized biologically active nanocomplexes |
| WO2023288046A1 (en) | 2021-07-15 | 2023-01-19 | President And Fellows Of Harvard College | Compositions and methods relating to cells with adhered particles |
| CN118871571A (zh) * | 2022-03-11 | 2024-10-29 | 西湖生物医药科技(上海)有限公司 | 一种靶向pd-1的工程化红细胞 |
| WO2026046110A1 (zh) * | 2024-08-26 | 2026-03-05 | 西湖生物医药科技(杭州)有限公司 | 一种基于工程化红细胞的新型药物递送系统 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6998393B2 (en) * | 2000-06-23 | 2006-02-14 | Biopharm Solutions, Inc. | Aquespheres, their preparation and uses thereof |
| WO2004032970A2 (en) * | 2002-10-10 | 2004-04-22 | Samir Mitragotri | Carriers attached to blood cells |
| WO2007084460A2 (en) * | 2006-01-18 | 2007-07-26 | Qps, Llc | Pharmaceutical compositions with enhanced stability |
| EP2714017B1 (en) | 2011-06-02 | 2018-08-01 | The Regents of The University of California | Membrane encapsulated nanoparticles and method of use |
| US11400114B2 (en) * | 2016-03-15 | 2022-08-02 | Massachusetts Institute Of Technology | Synthetically functionalized living cells for targeted drug delivery |
| JP6888239B2 (ja) | 2017-06-28 | 2021-06-16 | 株式会社 ＳＥＮＴＡＮ Ｐｈａｒｍａ | 腫瘍治療用腫瘍免疫活性促進剤及び腫瘍治療用医薬組成物 |
-
2020
- 2020-06-04 WO PCT/US2020/036040 patent/WO2020247576A1/en not_active Ceased
- 2020-06-04 IL IL288743A patent/IL288743B2/en unknown
- 2020-06-04 JP JP2021572295A patent/JP7561146B2/ja active Active
- 2020-06-04 AU AU2020287620A patent/AU2020287620B2/en active Active
- 2020-06-04 EP EP20818165.1A patent/EP3979994A4/en active Pending
- 2020-06-04 CN CN202080056426.2A patent/CN114222564A/zh active Pending
- 2020-06-04 CA CA3140681A patent/CA3140681A1/en active Pending
- 2020-06-04 US US17/616,760 patent/US20220323603A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022534796A5 (https=) | ||
| Bourquin et al. | Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists | |
| JP5704788B2 (ja) | 癌の治療および過剰増殖性疾患の治療のための、免疫遺伝子療法と化学療法の組み合わせ | |
| JP6731405B2 (ja) | ウイルス粒子を用いた癌免疫療法 | |
| IL288743B1 (en) | Compositions and methods relating to erythrocytes with adhered particles | |
| US20240076337A1 (en) | Dual cytokine fusion proteins comprising il-10 | |
| US20240002547A1 (en) | Therapeutic multi-targeting constructs and uses thereof | |
| US20230287075A1 (en) | Dual cytokine fusion proteins comprising multi-subunit cytokines | |
| KR102578682B1 (ko) | Il8의 emt 경로 차단 및 암 줄기 세포 극복(il8 bloking emt pathway and overcoming cancer stem cells) | |
| CN118695868A (zh) | 包含il-10的双细胞因子融合蛋白与过继细胞疗法或双特异性t细胞衔接器用于治疗癌症 | |
| KR960008009B1 (ko) | 인터류킨 및 이중-가닥 rna를 포함하는 상승작용화 조성물 | |
| WO2019213686A1 (en) | Therapeutic compositions and uses therefor | |
| TW201705977A (zh) | 作為治療疫苗之奈米顆粒 | |
| Brown et al. | Medical management of melanoma | |
| CN116271090B (zh) | 一种具有tlr9激动剂活性的dna纳米笼及其在制备抗肿瘤药物中的应用 | |
| CN114072506A (zh) | 用于调节免疫应答的二聚CpG寡核苷酸 | |
| Adachi et al. | Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatin | |
| CN118715239A (zh) | 包含多亚基细胞因子的双细胞因子融合蛋白 | |
| US20200339629A1 (en) | Therapeutic constructs comprising cmet binding peptides | |
| Zhu et al. | Synergistic Activation of Immunogenic Cell Death and the cGAS–STING Pathway by Engineered Zinc/Manganese‐Based Metal–Organic Framework Nanoplatforms for Colon Cancer Immunotherapy | |
| US20210198319A1 (en) | Cytotoxic peptides and conjugates thereof | |
| JP2022549742A (ja) | 腫瘍の相乗的阻害におけるペグインターフェロンおよびプロトオンコジーン産物標的阻害剤の応用 | |
| CN117695242A (zh) | 环二核苷酸自组装纳米粒子及其制备和应用 | |
| Kebede et al. | HGG-03. TRUNCATING MUTATIONS IN PPM1D COOPERATE WITH PI3K ALTERATIONS TO DRIVE PEDIATRIC DIFFUSE MIDLINE GLIOMAS | |
| CN119326872A (zh) | 一种治疗肿瘤的组合疗法及其应用 |